vs
Astrana Health, Inc.（ASTH）与Aveanna Healthcare Holdings, Inc.（AVAH）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Aveanna Healthcare Holdings, Inc.的1.5倍（$950.5M vs $621.9M），Aveanna Healthcare Holdings, Inc.净利率更高（2.3% vs 0.7%，领先1.6%），Astrana Health, Inc.同比增速更快（42.9% vs 22.2%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 14.0%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
ASTH vs AVAH — 直观对比
营收规模更大
ASTH
是对方的1.5倍
$621.9M
营收增速更快
ASTH
高出20.7%
22.2%
净利率更高
AVAH
高出1.6%
0.7%
两年增速更快
ASTH
近两年复合增速
14.0%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $621.9M |
| 净利润 | $6.6M | $14.1M |
| 毛利率 | — | 32.6% |
| 营业利润率 | 1.9% | 8.6% |
| 净利率 | 0.7% | 2.3% |
| 营收同比 | 42.9% | 22.2% |
| 净利润同比 | 184.4% | 132.8% |
| 每股收益（稀释后） | $0.12 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHAVAH
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $621.9M | ||
| Q2 25 | $654.8M | $589.6M | ||
| Q1 25 | $620.4M | $559.2M | ||
| Q4 24 | $665.2M | $519.9M | ||
| Q3 24 | $478.7M | $509.0M | ||
| Q2 24 | $486.3M | $505.0M | ||
| Q1 24 | $404.4M | $490.7M |
净利润ASTHAVAH
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $14.1M | ||
| Q2 25 | $9.4M | $27.0M | ||
| Q1 25 | $6.7M | $5.2M | ||
| Q4 24 | $-7.8M | $29.2M | ||
| Q3 24 | $16.1M | $-42.8M | ||
| Q2 24 | $19.2M | $13.9M | ||
| Q1 24 | $14.8M | $-11.2M |
毛利率ASTHAVAH
| Q4 25 | — | — | ||
| Q3 25 | — | 32.6% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 33.0% | ||
| Q3 24 | — | 31.4% | ||
| Q2 24 | — | 31.3% | ||
| Q1 24 | — | 29.7% |
营业利润率ASTHAVAH
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 8.6% | ||
| Q2 25 | 3.1% | 13.6% | ||
| Q1 25 | 3.3% | 9.3% | ||
| Q4 24 | 0.1% | 8.8% | ||
| Q3 24 | 5.9% | 6.7% | ||
| Q2 24 | 6.2% | 7.4% | ||
| Q1 24 | 7.5% | 4.7% |
净利率ASTHAVAH
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 1.4% | 4.6% | ||
| Q1 25 | 1.1% | 0.9% | ||
| Q4 24 | -1.2% | 5.6% | ||
| Q3 24 | 3.4% | -8.4% | ||
| Q2 24 | 3.9% | 2.8% | ||
| Q1 24 | 3.7% | -2.3% |
每股收益（稀释后）ASTHAVAH
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.06 | ||
| Q2 25 | $0.19 | $0.13 | ||
| Q1 25 | $0.14 | $0.03 | ||
| Q4 24 | $-0.14 | $0.15 | ||
| Q3 24 | $0.33 | $-0.22 | ||
| Q2 24 | $0.40 | $0.07 | ||
| Q1 24 | $0.31 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $145.9M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $779.3M | $9.2M |
| 总资产 | $2.2B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 141.83× |
8季度趋势，按日历期对齐
现金及短期投资ASTHAVAH
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $145.9M | ||
| Q2 25 | $342.1M | $100.7M | ||
| Q1 25 | $260.9M | $71.5M | ||
| Q4 24 | $290.8M | $84.3M | ||
| Q3 24 | $350.3M | $78.5M | ||
| Q2 24 | $327.7M | $47.7M | ||
| Q1 24 | $337.3M | $42.6M |
总债务ASTHAVAH
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
股东权益ASTHAVAH
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $9.2M | ||
| Q2 25 | $765.5M | $-12.0M | ||
| Q1 25 | $745.4M | $-100.1M | ||
| Q4 24 | $712.7M | $-123.6M | ||
| Q3 24 | $704.6M | $-156.4M | ||
| Q2 24 | $678.9M | $-119.0M | ||
| Q1 24 | $653.5M | $-136.3M |
总资产ASTHAVAH
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $1.8B | ||
| Q2 25 | $1.4B | $1.8B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.6B | ||
| Q2 24 | $1.3B | $1.7B | ||
| Q1 24 | $1.2B | $1.6B |
负债/权益比ASTHAVAH
| Q4 25 | — | — | ||
| Q3 25 | — | 141.83× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $33.2M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 2.36× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHAVAH
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $33.2M | ||
| Q2 25 | $90.9M | $51.6M | ||
| Q1 25 | $16.6M | $-8.6M | ||
| Q4 24 | $-10.9M | $13.4M | ||
| Q3 24 | $34.0M | $29.4M | ||
| Q2 24 | $23.2M | $1.8M | ||
| Q1 24 | $6.0M | $-12.0M |
自由现金流ASTHAVAH
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHAVAH
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHAVAH
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHAVAH
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 2.36× | ||
| Q2 25 | 9.65× | 1.91× | ||
| Q1 25 | 2.48× | -1.66× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 0.13× | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
